Lindbrook Capital’s Natus Medical Inc NTUS Stock Holding History

Lindbrook Capital’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-27	Closed	-$1K	–	1885
2020 Q2	$1K	Hold	27	–	–	﹤0.01%	1677
2020 Q1	$1K	Buy	+27	New	+$785	﹤0.01%	1637

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lindbrook Capital's NTUS Position: Q3 2020 in Review

Lindbrook Capital sold out of Natus Medical Inc (NTUS) in Q3 2020, closing a stake of 27 shares — an estimated $1K sold.

Lindbrook Capital first reported a position in NTUS in Q1 2020 and held it in 2 quarters. The position peaked at $1K in Q2 2020. 159 funds tracked by Wall St. Rank hold NTUS as of Q3 2020.

Lindbrook Capital reported no remaining Natus Medical Inc position as of Q3 2020 after selling out during the quarter.
Lindbrook Capital sold 27 Natus Medical Inc shares in Q3 2020, an estimated $1K.
Lindbrook Capital first reported a position in Natus Medical Inc in Q1 2020 and held it in 2 quarters.
Lindbrook Capital's Natus Medical Inc position peaked at $1K in Q2 2020.
159 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2020.

Based on Lindbrook Capital's 13F filing for Q3 2020, filed 3 Nov 2020.